Is Black Reishi different from regular Reishi mushroom?

Black Reishi refers to a specific cultivar or growth form of Ganoderma lucidum distinguished by a deeply pigmented, almost black lacquered cap, compared to the more common reddish-brown variety. While both contain β-(1,3)-(1,6)-D-glucans, ganoderic acids, and polysaccharides, no peer-reviewed comparative studies have quantified whether the Black Reishi cultivar contains meaningfully different concentrations of these bioactives. Consumers should treat Black Reishi marketing claims with caution until cultivar-specific analytical or clinical data are published.

What is the recommended dosage of Black Reishi mushroom?

No clinically validated dosage exists specifically for the Black Reishi cultivar. General Ganoderma lucidum research has used dried extract doses ranging from 1.5 g to 9 g per day of whole mushroom powder, or 1–1.5 g per day of standardized polysaccharide extract (standardized to ≥20% β-glucan content). Until Black Reishi-specific pharmacokinetic or dose-response studies are conducted, extrapolating from general Reishi dosing guidelines is the only available reference point.

Does Black Reishi mushroom boost the immune system?

In-vitro studies show that Ganoderma lucidum β-(1,3)-(1,6)-D-glucans activate macrophages and NK cells by binding Dectin-1 and TLR2 receptors, suggesting immunomodulatory potential. Small human trials using general Ganoderma extracts have shown increases in NK cell cytotoxicity and CD4+ T-cell counts, though effect sizes are modest and study quality is variable. No equivalent data exist for the Black Reishi cultivar specifically, so immune-boosting claims for this variant are not yet supported by direct human evidence.

Are there any side effects of taking Black Reishi supplements?

Based on general Ganoderma lucidum data, reported side effects include dry mouth, nausea, dizziness, and loose stools, affecting approximately 10–15% of participants in clinical trials lasting up to 16 weeks. Rare cases of hepatotoxicity have been associated with Reishi powder preparations (distinct from water-based extracts), though causality is difficult to confirm given polypharmacy in reported cases. Individuals taking anticoagulants, antiplatelet drugs, or hypoglycemic agents face the highest interaction risk and should consult a physician before use.

What compounds in Black Reishi are responsible for its antioxidant activity?

The primary antioxidant compounds identified in Ganoderma lucidum include ganoderic acids (lanostane-type triterpenoids), polysaccharide-protein complexes, and phenolic compounds such as protocatechuic acid. In DPPH and ABTS radical scavenging assays, polysaccharide fractions have demonstrated IC50 values in the range of 0.5–2.0 mg/mL, depending on extraction method and fraction purity. These findings are from in-vitro laboratory models only; whether these antioxidant effects translate to meaningful in-vivo oxidative stress reduction in humans at supplement doses has not been established for any Ganoderma cultivar.

Is Black Reishi safe to take during pregnancy or while breastfeeding?

There is insufficient safety data for Black Reishi during pregnancy and breastfeeding, as no clinical trials have been conducted on this cultivar in these populations. Given the lack of established safety evidence, pregnant and nursing women should consult with a healthcare provider before use. General Ganoderma lucidum supplementation during these periods remains a matter of medical caution due to limited human studies.

Does Black Reishi interact with common medications like blood thinners or diabetes drugs?

While Black Reishi contains bioactive compounds like polysaccharides that may have biological activity, no clinical interaction studies exist specifically for this cultivar with medications. Ganoderma lucidum in general may theoretically interact with anticoagulants or antidiabetic medications based on preliminary research, but human evidence is lacking. Anyone taking prescription medications should consult their healthcare provider before adding Black Reishi supplements.

What is the strongest form of Black Reishi supplement—extract, powder, or whole fruiting body?

Black Reishi supplements are available as extracts, powders, and whole fruiting body products, but no comparative bioavailability studies exist to determine which form is most effective. Extracts are typically more concentrated in polysaccharides (the primary active compounds) but lack clinical validation specific to Black Reishi. Selection should be based on product quality standards and third-party testing rather than form alone, given the absence of human efficacy data.

Ganoderma lucidum 'Black Reishi'

Black Reishi (Ganoderma lucidum) is a cultivar characterized by its dark, lacquered fruiting body and high concentrations of β-(1,3)-(1,6)-D-glucans and triterpene compounds such as ganoderic acids. These bioactives are thought to modulate immune signaling via Toll-like receptor 2 (TLR2) activation and inhibit pro-inflammatory cytokines including TNF-α and IL-6.

Category: Mushroom/Fungi Evidence: 2/10 Tier: Traditional

Ganoderma lucidum 'Black Reishi' — Hermetica Encyclopedia

Origin & History

Ganoderma lucidum 'Black Reishi' is a dark-pigmented cultivar variant of the Reishi mushroom, a basidiomycete fungus native to Asia and cultivated worldwide on wood logs, sawdust, or liquid media. Production involves grinding dried fruiting bodies, defatting, heat treatment (70-180°C), followed by ethanol extraction (75% at 40°C for 8h) or dual extraction methods targeting both water-soluble polysaccharides and alcohol-soluble triterpenes.

Historical & Cultural Context

Ganoderma lucidum (including variants like Reishi) has been used in Traditional Chinese Medicine for over 2,000 years to support vitality, immunity, and longevity. However, the Black Reishi cultivar is not specifically distinguished in historical texts or traditional systems.

Health Benefits

• No human clinical trials exist specifically for Black Reishi cultivar - evidence quality: absent
• General Ganoderma lucidum shows antioxidant activity via DPPH/ABTS assays in laboratory tests - evidence quality: preliminary (in-vitro only)
• Contains β-(1,3)-(1,6)-D-glucans and polysaccharides (68.5 g/kg in dry powders) that may support immune function - evidence quality: preliminary (compositional data only)
• Heat-treated extracts show altered phenolic content which may contribute to antioxidant potential - evidence quality: preliminary (analytical data only)
• Traditional use suggests support for vitality and longevity, though not specific to Black Reishi variant - evidence quality: traditional only

How It Works

Black Reishi's β-(1,3)-(1,6)-D-glucans bind Dectin-1 receptors on macrophages and dendritic cells, triggering NF-κB and MAPK signaling cascades that upregulate innate immune responses. Ganoderic acids (triterpenoids) inhibit HMG-CoA reductase activity and suppress NF-κB nuclear translocation, potentially reducing inflammatory mediator production. Additionally, polysaccharide fractions have demonstrated free-radical scavenging via inhibition of lipid peroxidation in DPPH and ABTS in-vitro assay models, though receptor-level confirmation in human tissue remains absent.

Scientific Research

No human clinical trials, RCTs, or meta-analyses exist specifically for Ganoderma lucidum 'Black Reishi' cultivar in the available research. All available data focuses on general G. lucidum or G. lingzhi strains, with no PubMed PMIDs provided for clinical studies on this specific variant.

Clinical Summary

No human clinical trials have been conducted specifically on the Black Reishi cultivar, making cultivar-specific efficacy claims unsupported by clinical evidence. General Ganoderma lucidum research includes small randomized trials (n=30–100) examining immune markers, fatigue in cancer patients, and blood glucose modulation, with modest but inconsistent results. A 2012 randomized trial in colorectal cancer patients (n=68) found polysaccharide extract improved NK cell activity, but effect sizes were small and blinding quality was moderate. Overall, the evidence base for any Ganoderma lucidum product remains preliminary, and the Black Reishi cultivar specifically lacks the human data required to substantiate therapeutic claims.

Nutritional Profile

Black Reishi (Ganoderma lucidum 'Black Reishi') is a woody, non-culinary mushroom typically consumed as dried powder or extract rather than as a whole food. Nutritional and bioactive composition is based on general Ganoderma lucidum data, as cultivar-specific analytical data for 'Black Reishi' is extremely limited. **Macronutrients (per 100 g dry weight, approximate):** Protein: 7–18 g (contains all essential amino acids but in low quantities; digestibility is limited by chitin cell walls); Total carbohydrates: 24–76 g (highly variable depending on extraction and drying method), of which a significant fraction is non-digestible polysaccharides and chitin-based dietary fiber (approx. 28–58 g); Fat: 1.5–5.0 g (includes sterols and fatty acids); Calories: ~200–370 kcal. **Key Bioactive Compounds:** β-(1,3)-(1,6)-D-glucans and heteropolysaccharides: 68.5 g/kg dry powder reported in general G. lucidum; these are primary immunomodulatory candidates but have low oral bioavailability unless hot-water or dual-extracted. Ganoderic acids (triterpenoids): over 150 identified across G. lucidum species, typically 1–5% of dry weight in fruiting body; specific concentrations in Black Reishi cultivar not characterized; ganoderic acids A, B, C, D, and F are most studied; triterpenoids are more soluble in ethanol extracts than water. Ganodermanontriol and lucidenic acids: minor triterpenoids, concentrations not well-quantified for this cultivar. Ergosterol (provitamin D2): approximately 0.3–0.7% dry weight; can convert to vitamin D2 upon UV exposure. **Minerals (per 100 g dry weight, approximate):** Potassium: 200–600 mg; Phosphorus: 100–350 mg; Calcium: 30–80 mg; Magnesium: 20–70 mg; Iron: 2–15 mg; Zinc: 3–9 mg; Selenium: 1–7 µg (highly dependent on substrate); Germanium: trace amounts reported (0.01–0.05% in some analyses, though significance is debated). **Vitamins:** B-vitamins present in small amounts (riboflavin ~0.2–0.5 mg/100 g, niacin ~3–8 mg/100 g); Vitamin D2 negligible unless UV-treated. **Other bioactive constituents:** Peptidoglycans (immunomodulatory); small molecular weight proteins including LZ-8 (fungal immunomodulatory protein, ~12 kDa); nucleosides (adenosine and its analogs, ~0.01–0.1%); sterols including ganoderol A and B. **Bioavailability Notes:** Whole dried powder has limited bioavailability due to chitin cell walls; hot-water extraction improves polysaccharide availability while ethanol/dual extraction improves triterpenoid access. β-glucan oral bioavailability is inherently low (estimated <5% systemic absorption), though immune effects may be mediated via gut-associated lymphoid tissue (Peyer's patches) and do not require systemic absorption. Ganoderic acids are moderately lipophilic and may benefit from co-consumption with dietary fat. Typical supplemental doses range from 1.5–9 g/day of dried powder or 1–1.5 g/day of concentrated extract; these doses are far below levels where macronutrient contributions are meaningful. No cultivar-specific compositional analysis distinguishes 'Black Reishi' from standard G. lucidum; all values should be considered approximate and extrapolated.

Preparation & Dosage

No clinically studied dosage ranges are available for Black Reishi extracts, powders, or standardized forms as human trials are absent. Cultivation yields include 22.1 g/L biomass in liquid fermentation, but these are not linked to clinical dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Vitamin D3, Turkey Tail, Shiitake, Cordyceps

Safety & Interactions

Ganoderma lucidum preparations are generally well tolerated in short-term use (up to 16 weeks), but reported adverse effects include dry mouth, dizziness, and gastrointestinal upset in roughly 10–15% of users in trial populations. Clinically significant drug interactions include additive anticoagulant effects when combined with warfarin or aspirin, as ganoderic acids inhibit platelet aggregation; concurrent use should be medically supervised. Ganoderma extracts may potentiate hypoglycemic agents by independently lowering fasting blood glucose, requiring glucose monitoring in diabetic patients. Safety in pregnancy and lactation has not been evaluated in controlled studies, and use is not recommended in these populations or in individuals with autoimmune conditions receiving immunosuppressant therapy.

Found in Hermetica Products

Eternity

Functional mushroom gummies with lion's mane, reishi, cordyceps, chaga and maitake.

Hush

Botanical nighttime gummies with reishi, L-theanine, chamomile and passionflower.

Cozy

Warming adaptogenic chai with ashwagandha, lion's mane and reishi.